VMP 35824911000001104

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Testosterone 20mg/g transdermal gel (23mg per actuation) with applicator
BNF code 0604020K0AABRBR
Virtual Therapeutic Moiety Testosterone
Abbreviated name Testosterone 20mg/g gel (23mg per actuation) with applicator
Basis of preferred name rINN - Recommended International Non-proprietary
Date of name applicability 1 May 2024
Previous name Testosterone 20mg/g transdermal gel (23mg per actuation)
Basis of previous name rINN - Recommended International Non-proprietary
Reason for name change Other
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.150
Unit dose form units gram
Unit dose unit of measure actuation
Virtual Product Ingredient
Ingredient Testosterone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 20.000
Strength value numerator unit mg
Strength value denominator 1.000
Strength value denominator unit gram
Ontology Drug Form & Route
Form & Route gel.transdermal
Dose Form
Formulation Transdermal gel
Drug Route
Route Transdermal
Controlled Drug Prescribing Information
Controlled Drug category Schedule 4 (CD Anab)
Date of applicability 5 Oct 2018
Previous Controlled Drug information Schedule 4 (CD Benz)
Actual Medicinal Products
Testavan 20mg/g transdermal gel (The Simple Pharma Company UK Ltd)
Virtual Medicinal Product Packs
Testosterone 20mg/g transdermal gel (23mg per actuation) with applicator 256.5 gram
Testosterone 20mg/g transdermal gel (23mg per actuation) with applicator 85.5 gram

dm+d data retrieved from TRUD: release NHSBSA_5.3.0_20240527000001, imported on 27th May 2024 at 05:27:36.

Feedback